Suppr超能文献

抗疟臭氧化物阿特非诺(OZ439)的构效关系

Structure-Activity Relationship of the Antimalarial Ozonide Artefenomel (OZ439).

作者信息

Dong Yuxiang, Wang Xiaofang, Kamaraj Sriraghavan, Bulbule Vivek J, Chiu Francis C K, Chollet Jacques, Dhanasekaran Manickam, Hein Christopher D, Papastogiannidis Petros, Morizzi Julia, Shackleford David M, Barker Helena, Ryan Eileen, Scheurer Christian, Tang Yuanqing, Zhao Qingjie, Zhou Lin, White Karen L, Urwyler Heinrich, Charman William N, Matile Hugues, Wittlin Sergio, Charman Susan A, Vennerstrom Jonathan L

机构信息

College of Pharmacy, University of Nebraska Medical Center , 986125 Nebraska Medical Center, Omaha, Nebraska 68198, United States.

Centre for Drug Candidate Optimisation, Monash Institute of Pharmaceutical Sciences, Monash University (Parkville Campus) , 381 Royal Parade, Parkville, Victoria 3052, Australia.

出版信息

J Med Chem. 2017 Apr 13;60(7):2654-2668. doi: 10.1021/acs.jmedchem.6b01586. Epub 2017 Jan 18.

Abstract

Building on insights gained from the discovery of the antimalarial ozonide arterolane (OZ277), we now describe the structure-activity relationship (SAR) of the antimalarial ozonide artefenomel (OZ439). Primary and secondary amino ozonides had higher metabolic stabilities than tertiary amino ozonides, consistent with their higher pK and lower log D values. For primary amino ozonides, addition of polar functional groups decreased in vivo antimalarial efficacy. For secondary amino ozonides, additional functional groups had variable effects on metabolic stability and efficacy, but the most effective members of this series also had the highest log D values. For tertiary amino ozonides, addition of polar functional groups with H-bond donors increased metabolic stability but decreased in vivo antimalarial efficacy. Primary and tertiary amino ozonides with cycloalkyl and heterocycle substructures were superior to their acyclic counterparts. The high curative efficacy of these ozonides was most often associated with high and prolonged plasma exposure, but exposure on its own did not explain the presence or absence of either curative efficacy or in vivo toxicity.

摘要

基于从抗疟药奥佐烷(OZ277)的发现中获得的见解,我们现在描述抗疟药奥佐芬诺(OZ439)的构效关系(SAR)。伯氨基和仲氨基奥佐烷比叔氨基奥佐烷具有更高的代谢稳定性,这与其更高的pK值和更低的log D值一致。对于伯氨基奥佐烷,添加极性官能团会降低体内抗疟效力。对于仲氨基奥佐烷,额外的官能团对代谢稳定性和效力有不同影响,但该系列中最有效的成员也具有最高的log D值。对于叔氨基奥佐烷,添加具有氢键供体的极性官能团会增加代谢稳定性,但会降低体内抗疟效力。具有环烷基和杂环亚结构的伯氨基和叔氨基奥佐烷优于其无环类似物。这些奥佐烷的高治愈效力最常与高且持久的血浆暴露相关,但暴露本身并不能解释治愈效力或体内毒性的有无。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验